We're using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience.

By continuing to use our website without changing the settings, you're agreeing to our use of cookies.

Find out more
For more information, go to

Treating Achilles tendinopathy

Issue 35 Synovium (Spring 2012)

Download this issue (opens in new window)(419.1 KB)

Three years ago we reported a randomised controlled trial that cast doubt on the value of platelet-rich plasma (PRP) for the treatment of Achilles tendinopathy.

A recent meta-analysis of trials of PRP in bone and soft tissue disorders1 increases this doubt, finding no significant benefit of the treatment in 6 randomised controlled trials and 3 prospective cohort studies. However as one novel treatment appears to be hitting the buffers another emerges into the research spotlight.

In a randomised controlled trial2 40 Achilles tendons in 32 patients with a diagnosis of Achilles tendinosis (tendinopathy) were injected with skin-derived fibroblasts suspended in autologous plasma or with local anaesthetic. Significant improvement in pain scores was seen in the patients with unilateral tendinopathy injected with fibroblasts – but intriguingly not in the 8 patients with bilateral pathology.

No significant adverse effects were observed, and the authors propose that this new treatment should be subject to large-scale trials.

Synovium archives

Browse previous issues of Synovium (all issues available as downloadable PDFs)

We're now

Versus Arthritis.

You're being taken through to our new website in order to finish your donation.

Thank you for your generosity.

For more information, go to
Arthritis Research UK fund research into the cause, treatment and cure of arthritis. You can support Arthritis Research UK by volunteering, donating or visiting our shops.